Improved Health Related Quality of Life Outcomes in Subjects With Moderate to Severe COPD Treated With Nebulized Arformoterol Tartrate: Results From a 52-Week Trial

Improved Health Related Quality of Life Outcomes in Subjects With Moderate to Severe COPD Treated With Nebulized Arformoterol Tartrate: Results From a 52-Week Trial

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Donohue, James, MD, Bollu, Vamsi, PhD, Hanania, Nicola, MD
Format: Tagungsbericht
Sprache:eng
Schlagworte:
Pulmonary/Respiratory
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 736B
container_issue 4
container_start_page 736A
container_title
container_volume 144
creator Donohue, James, MD
Bollu, Vamsi, PhD
Hanania, Nicola, MD
description
doi_str_mv 10.1378/chest.1704638
format Conference Proceeding
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1378_chest_1704638</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0012369216433714</els_id><sourcerecordid>S0012369216433714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1808-2212a93b12004c738d02201c5a2f5080bd104f851abcd37d63a8fee3699c43cf3</originalsourceid><addsrcrecordid>eNp1kc1qGzEUhUVpoG7SZfZ6gUl1pfntohDc5gecuq0dshQazRWRo7GCpDG4z9MHjexkVehKHDjnXN3vEnIO7AJE037WjxjTBTSsrEX7jsygE1CIqhTvyYwx4IWoO_6BfIxxw7KGrp6Rv7fjc_A7HOgNKpce6W90KmX5a1LOpj31hi6sQbqckvYjRmq3dDX1G9Qp0gebE3d-wJAzNHm6wh0GpPPlz290HfDYdDT9wH5y9k-Wl8H4MPqEwTu6ViEdsl_y3Di5XHkV_EgVrXjxgPiUS6xyZ-TEKBfx09t7Su6vvq_nN8VieX07v1wUGlrWFpwDV53ogTNW6ka0A-Ocga4UNxVrWT8AK01bger1IJqhFqo1iJlKp0uhjTglxWuvDj7GgEY-BzuqsJfA5AGxPCKWb4izv3n1Y_7UzmKQUVvcahxsyHzk4O1_k1__SWpnt1Yr94R7jBs_hW3eVIKMXDK5OpzvcD2oSyEaKMUL2AqYnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>conference_proceeding</recordtype></control><display><type>conference_proceeding</type><title>Improved Health Related Quality of Life Outcomes in Subjects With Moderate to Severe COPD Treated With Nebulized Arformoterol Tartrate: Results From a 52-Week Trial</title><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Donohue, James, MD ; Bollu, Vamsi, PhD ; Hanania, Nicola, MD</creator><creatorcontrib>Donohue, James, MD ; Bollu, Vamsi, PhD ; Hanania, Nicola, MD</creatorcontrib><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.1704638</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Pulmonary/Respiratory</subject><ispartof>Chest, 2013, Vol.144 (4), p.736A-736B</ispartof><rights>The American College of Chest Physicians</rights><rights>2013 The American College of Chest Physicians</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,776,780,785,786,23910,23911,25119,27904</link.rule.ids></links><search><creatorcontrib>Donohue, James, MD</creatorcontrib><creatorcontrib>Bollu, Vamsi, PhD</creatorcontrib><creatorcontrib>Hanania, Nicola, MD</creatorcontrib><title>Improved Health Related Quality of Life Outcomes in Subjects With Moderate to Severe COPD Treated With Nebulized Arformoterol Tartrate: Results From a 52-Week Trial</title><title>Chest</title><subject>Pulmonary/Respiratory</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>conference_proceeding</rsrctype><creationdate>2013</creationdate><recordtype>conference_proceeding</recordtype><recordid>eNp1kc1qGzEUhUVpoG7SZfZ6gUl1pfntohDc5gecuq0dshQazRWRo7GCpDG4z9MHjexkVehKHDjnXN3vEnIO7AJE037WjxjTBTSsrEX7jsygE1CIqhTvyYwx4IWoO_6BfIxxw7KGrp6Rv7fjc_A7HOgNKpce6W90KmX5a1LOpj31hi6sQbqckvYjRmq3dDX1G9Qp0gebE3d-wJAzNHm6wh0GpPPlz290HfDYdDT9wH5y9k-Wl8H4MPqEwTu6ViEdsl_y3Di5XHkV_EgVrXjxgPiUS6xyZ-TEKBfx09t7Su6vvq_nN8VieX07v1wUGlrWFpwDV53ogTNW6ka0A-Ocga4UNxVrWT8AK01bger1IJqhFqo1iJlKp0uhjTglxWuvDj7GgEY-BzuqsJfA5AGxPCKWb4izv3n1Y_7UzmKQUVvcahxsyHzk4O1_k1__SWpnt1Yr94R7jBs_hW3eVIKMXDK5OpzvcD2oSyEaKMUL2AqYnA</recordid><startdate>201310</startdate><enddate>201310</enddate><creator>Donohue, James, MD</creator><creator>Bollu, Vamsi, PhD</creator><creator>Hanania, Nicola, MD</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201310</creationdate><title>Improved Health Related Quality of Life Outcomes in Subjects With Moderate to Severe COPD Treated With Nebulized Arformoterol Tartrate: Results From a 52-Week Trial</title><author>Donohue, James, MD ; Bollu, Vamsi, PhD ; Hanania, Nicola, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1808-2212a93b12004c738d02201c5a2f5080bd104f851abcd37d63a8fee3699c43cf3</frbrgroupid><rsrctype>conference_proceedings</rsrctype><prefilter>conference_proceedings</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Pulmonary/Respiratory</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Donohue, James, MD</creatorcontrib><creatorcontrib>Bollu, Vamsi, PhD</creatorcontrib><creatorcontrib>Hanania, Nicola, MD</creatorcontrib><collection>CrossRef</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Donohue, James, MD</au><au>Bollu, Vamsi, PhD</au><au>Hanania, Nicola, MD</au><format>book</format><genre>proceeding</genre><ristype>CONF</ristype><atitle>Improved Health Related Quality of Life Outcomes in Subjects With Moderate to Severe COPD Treated With Nebulized Arformoterol Tartrate: Results From a 52-Week Trial</atitle><btitle>Chest</btitle><date>2013-10</date><risdate>2013</risdate><volume>144</volume><issue>4</issue><spage>736A</spage><epage>736B</epage><pages>736A-736B</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><pub>Elsevier Inc</pub><doi>10.1378/chest.1704638</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-3692
ispartof Chest, 2013, Vol.144 (4), p.736A-736B
issn 0012-3692
1931-3543
language eng
recordid cdi_crossref_primary_10_1378_chest_1704638
source Journals@Ovid Complete; Alma/SFX Local Collection
subjects Pulmonary/Respiratory
title Improved Health Related Quality of Life Outcomes in Subjects With Moderate to Severe COPD Treated With Nebulized Arformoterol Tartrate: Results From a 52-Week Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T05%3A20%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=proceeding&rft.atitle=Improved%20Health%20Related%20Quality%20of%20Life%20Outcomes%20in%20Subjects%20With%20Moderate%20to%20Severe%20COPD%20Treated%20With%20Nebulized%20Arformoterol%20Tartrate:%20Results%20From%20a%2052-Week%20Trial&rft.btitle=Chest&rft.au=Donohue,%20James,%20MD&rft.date=2013-10&rft.volume=144&rft.issue=4&rft.spage=736A&rft.epage=736B&rft.pages=736A-736B&rft.issn=0012-3692&rft.eissn=1931-3543&rft_id=info:doi/10.1378/chest.1704638&rft_dat=%3Celsevier_cross%3ES0012369216433714%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0012369216433714&rfr_iscdi=true